← All organizations

Boston Pharmaceuticals

For profitContributed to NMEWebsite ↗

Also known as: Boston Pharmaceuticals | Boston Pharmaceuticals, Vice President, Clinical Development | COMMAVE THERAP

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

First marketed drug

First NDA

Last known activity

Apr 9, 2025

Timeline

2010s

Jun 1, 2015
Boston Pharmaceuticals— Founded

2020s

Mar 2, 2021
dexmethylphenidate— NDA Secondary Org
Mar 2, 2021
serdexmethylphenidate— NDA Organization

Drugs by trial phase (12 distinct, 12 trials)

Phase 2 (3 own, 0 via acquisition)

Phase 1 (9 own, 0 via acquisition)

Indications

Studied for

Marketed drugs (2)

Recent trials (14)

NCT06920043Lead sponsorPhase 2Apr 9, 2025
NCT04880031Lead sponsorPhase 2Sep 30, 2021
NCT04221906Study directorPhase 1Jan 31, 2020
NCT04221906Lead sponsorPhase 1Jan 31, 2020
NCT04163263Lead sponsorPhase 1Nov 4, 2019
NCT04514237Lead sponsorPhase 1Sep 12, 2019
NCT03977155Lead sponsorPhase 2Jun 4, 2019
NCT03960450Study directorPhase 1Apr 23, 2019
NCT03960450Lead sponsorPhase 1Apr 23, 2019
NCT03780517Lead sponsorPhase 1Dec 12, 2018
NCT03464058Lead sponsorPhase 1Mar 21, 2018
NCT03371251Lead sponsorPhase 1/Phase 2Feb 7, 2018
NCT03328494Lead sponsorPhase 1Oct 13, 2017
NCT03036865Lead sponsorPhase 1Jan 1, 2017

Details

Founded: Cambridge, MA, US Jun 1, 2015
First NDA: Mar 2, 2021
Last known activity: Apr 9, 2025